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ABSTRACT 
 
Synthesis of Resveratrol Esters and Aliphatic Acids 
by 
Stanley Mofor Jing 
Resveratrol (RV) is a naturally occurring phytoalexin of the stilbenoid family produced by some 
plant species, and present in grape skin, peanuts, and red wine. It has been found to exhibit anti-
cancer, anti-inflammatory, anti-viral, anti-aging, cardio protective, and anti-oxidant properties. 
Bioavailability is a huge setback that limits the potentials of RV. As a result, efforts have been 
made to design and synthesize RV esters and aliphatic acids in an attempt to increase its 
bioavailability, solubility in water, and possibly improving its biological activities. Resveratrol 
esters, 3,5,4’-triacetyloxystilbene (2) and  Methyl 1,1’,1’’- (3,4’,5-stilbenyl)-1,6-hexanedioate 
(3) have been synthesized.  Compound 3 is a new compound, synthetic yield is 88%, and purity 
is above 95% based on NMR integration. Both 2 and 3 are good candidates for biological 
evaluation. 3 was used as a precursor in the synthesis of resveratrol aliphatic acid, 8-(3’,5’-
dihydroxylstilbene-4’’-oxy)-3,6-dioxocotanoic acid(9). First, 2 was hydrolyzed to resveratrol 
diester, 3,5-diacetyloxystilbene (4). Mitsunobu reaction of 4 and methyl 8-hydroxy-3,6-
dioxooctanoate (7) was then carried out to afford methyl 8-(3’,5’-diacetyoxystilben-4’’-oxy)-3.6-
dioxooctanoate(5), which was then hydrolyzed to afford 9 in total 43.6 % yield. Structures of all 
newly synthesized compounds were confirmed by 
1
H and 
13
C NMR spectroscopy. 
 
 
 
 
 
 
 
 
 3 
 
DEDICATION 
In loving memory of my late sister, Sally Sisuh Jing. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 4 
 
ACKNOWEDGEMENTS 
I thank the Almighty God for his strength, grace, and blessings throughout this research. 
My sincere gratitude goes to Dr. Yu Lin Jiang for accepting me as his graduate research 
student and for his mentoring, I learned a lot.  
My special thanks go to ETSU and Department of Chemistry for awarding me a graduate 
assistantship that supported me throughout my studies. 
Special thanks also go to Dr. Kady and Dr. Wardeska for serving on my committee and 
for all their guidance and support. 
My appreciation also goes to all faculty and staff of the Chemistry Department for their 
imparted knowledge and support throughout my training process. I thank Walt and Tom for all 
their help. 
Special thanks to Dr. Mosheni for all his help with instrumentation especially getting the 
NMR instrument back to working condition whenever it was down. 
Special thanks to Jillian, chemistry executive aide, for all her help with documentations 
and administrative affairs. 
Finally, I wish to extend my sincere gratitude to my colleague, Marian, for her help and 
support, my house mates, Jude lakbub. Nkongho Atem-Tambe . Special thanks to all graduate 
students; Thomas, Loren, Mary, Alexander, Kenneth, Ojo, Yasmine,  
 
 
 
 
 
 
 
 
 
 
 5 
 
CONTENTS                                               
                  Page 
ABSTRACT………………………………………………………………………………………2 
DEDICATION……………………………………………………………………………………3 
ACKNOWLEDGEMENTS………………………………………………………………………4 
LIST OF FIGURES………………………………………………………………………………9 
LIST OF SCHEMES…………………………………………………………………………….10 
Chapter  
  1. INTRODUCTION…………………………………………………………………….12 
 Cancer……………………………………………………………………………………13 
  Nomenclature and Types of Cancer…………………..………………………….13 
  Causes and Prevention of Cancer...………………………………………….…..14 
  Treatment Options……………………………………………………………….15 
   Chemotherapy……………………………………………………………15 
   Radiation Therapy………………………………………………………..16 
   Surgical Oncology……………………………………………………….17 
 Bioactive Natural Products……………………………………………………................17 
  Plant Kingdom………………………………………...…………………………18 
  Microbial World………………………………………………………………….19 
  Marine World………………………………………………………………….…20 
  Animal Sources…………………………………………………………….…….20 
 Antioxidants…………………………………………………………………….………..20 
 Phenolic Compounds and Polyphenols………...………………………………..……….22 
  Simple Phenolic…………………………………………………….……………23 
  Cinnamic Acids……………..………..……………………………….………….23 
  Flavones………………………………………………………...…….………….24 
 6 
 
  Napthaquinones and Anthraquinones……………………………………………24 
 Stilbenes and its Derivatives……………………………………………...……………...24 
  Isomerism………………………………………………………….……………..25 
  Derivatives of Stilbene………….….….………………….……….……………..25 
   Piceatonnol……………….….……………………….….…………….…26 
   Pinosylin………………...……….………………………………………26 
   Pterostilbene…………………..…..……………………………………...27 
 Resveratrol……………………………………………………………………………….28 
  Nomenclature and Structure…………………………………………………..…28 
  Isomerism………………………………………………………………….……..29 
  Chemical and Physical Properties………………………………………….…….29 
  History and Sources……………………………………………………………...29 
  The French Paradox…………….…………………………………………….….30 
  Reactivity……………………………………………………………………..….30 
  Dietary Supplement………………………………………………………….…..31 
  Reported Biological Activities…………………………………………..……….32 
  Recent Applications………………………………………………………….…..33 
  Biosynthesis of Resveratrol…………………………………………………..….33 
  Chemical Synthesis of Resveratrol……………………………………….….…..35 
  Pharmacokinetics…………………………………………………………….…..36 
  Interesting Resveratrol Analogues……………….…………………..….…...….37 
  Drawbacks of Resveratrol……….………………………………………….……40 
 Objectives of Research……………………………………………………………….….41 
 Synthesis Design…………………………………………………………....……………41 
  Method A………………………………………….….………………………….43 
 7 
 
  Method B………………………………………….….……………………….....43 
  Method C………………………………………………………..……………….43 
  Total synthesis of Aliphatic Acid………………………………………………..43 
 The Mitsunobu Reaction…................................................................................................45 
  Example of Mitsunobu Reaction………………………………………………...45 
  Mechanism of Mitsunobu Reaction………………………………….…………..46 
 Proposed Synthetic Pathway for Compound 2, and 4……………………….….…….…47 
 Proposed Synthetic Pathway for Compound 3………………………………….…….…48 
 Proposed Synthetic Pathway for Compound 5…………………………………….….…48 
 Proposed Synthetic Pathway for Compound 6………………………………………..…49 
 Proposed Synthetic Pathway for Compound 9………………………………………..…49 
2. RESULTS AND DISCUSSION  
 Synthesis of 3,5,4’-triacetyloxystilbene, 2..……………………………………………..50 
 Synthesis of methyl 1,1’,1’’-(3,4’,5-stilbenyl)1,6-hexanedioate, 3……………………..50 
 Synthesis of 3,5,4’-diacetyloxystilbene, 4.……………………………………….……..51 
 Synthesis of methyl 8-(3’,5’-diacetyoxystilbene-4’’-oxy)-3,6-dioxooctanoate, 5..…….51 
Synthesis of 8-(3’,5’-dihydroxylstilbene-4’’-oxy)-3,6-dioxocotanoic Acid, 9…………52 
 Synthesis of 4’-(2’,3’-di-O-acetyladenosine)-3,5-Di-O-acetylstilbene, 6……………....53 
 Conclusions………………………………………………………………………..…….54 
  Method A………………………………………………………………………...54 
  Method B………………………………………………………………………...54 
  Method C………………………………………………………………………...55 
  Total Synthesis of Aliphatic Acid………………………………………….…….55 
2. EXPERIMENTAL………………………………………………………………………….…56 
 General Methods…………………………………………………………………………56 
 8 
 
 Experimental Procedures………………………………………………………….……..56 
  Synthesis of 3,5,4’-triacetyloxystilbene………………………………………….56 
  Synthesis of methyl 1,1’,1’’-(3,4’,5-stilbenyl)1,6-hexanedioate………………. 57 
  Synthesis of 3,5,4’-diacetyloxystilbene ………………………………….……...58 
  Synthesis of methyl 8-(3’,5’-diacetyoxystilbene-4’’-oxy)-3.6-dioxooctanoate....59 
  Synthesis of 8-(3’,5’-dihydroxylstilbene-4’’-oxy)-3,6-dioxocotanoic Acid …...59 
Synthesis of 4’-(2’,3’-di-O-acetyladenosine)-3,5-Di-O-acetylstilbene……….....60  
 REFERENCES………………………………………………………………………..…61 
 APPENDICIES………………………………………………………………………..…65 
  APPENDIX A: 
1
H NMR Spectrum of Compound 2 in CCl3D……………....…65 
  APPENDIX B:
 1
H NMR Spectrum of Compound 4 in CCl3D………...…….….66 
  APPENDIX C: 
1
H NMR Spectrum of Compound 5 in CCl3D……………….....67 
  APPENDIX D:
 1
H NMR Spectrum of Compound 9 in acetone-d6/MeOD……...68 
  APPENDIX E: 
1
H NMR Spectrum of Compound 3 in CCl3D…………………..69 
  APPEDNIX F: 
13
C NMR Spectrum of Compound 3 in CCl3D……………….…70 
 VITA..………………..……………………………………………………………….….71 
 
 
 
 
   
 
 
 
 9 
 
LIST OF SCHEMES 
Scheme                                                                                                                                     Page 
1. Resonance structures from proton abstraction 4’-hydroxyl group……………………..……31 
2. Resonance structures from proton abstraction 3 or 5-hydroxyl group……………..….…….32 
3. Biosynthesis of Resveratrol…..………………………………………………….….……….34 
4. Vinylsilane Heck reaction for synthesis of Resveratrol.………………………….…...…….35 
5. Optimized Honrner-Emmons synthesis of Resveratrol. …………………………….………35 
6. Proposed synthetic metabolic pathway of RV in human liver cytosol in vitro…………..….36 
7. Synthesis design of Resveratrol esters….………………………………………………...…42 
8. Synthesis of Resveratrol aliphatic acid………………………………………………………44 
9. Mitsunobu reaction by Bruno et al…………………………………………………………..46 
10. Mechanism of Mitsunobu Reaction………………………………………………………….47 
11. Synthesis of di and tri- esters….……………………………………………………….…….47 
12. Synthesis of long chain tri-esters…………………………………………………………….48 
13. Mitsunobu reaction for synthesis of compound 5……………………………………………48 
14. Hydrolysis of ester to acid……………………………………………………………….…..49 
15. Mitsunobu reaction with 2’, 3’-di-O-Acetyl adenosine…...………………………….……..49 
 
 
 
 
 10 
 
LIST OF FIGURES 
 Figure                                                                                                                                        Page 
1. Simple phenolics………………………………………………………………………..…..23 
2. Structures of selected cinamic acids and flavones……………………………………..…...23 
3. Structure of napthaquinones…………………………………………………………….…..24 
4. Structure of cis and tans isomers of stilbene…………………………………………….….25 
5. Structure of piceatonnol………………………………………………………………….....26 
6. Structure of pinosylvin…………………………………………………………………...…27 
7. Structure of pterostilbene…………………………………………………………….…..…27 
8. Structure of Resveratrol, IUPAC numbering given….……………………………….….....28 
9. Structure of RV isomers………………………………………………………………..…...29 
10. Structure of selected analouges  by Chen et al………………………………….….……….37 
11. Resveratrol derivatives by Jiang………………………………………………………….…38 
12. Resveratrol derivatives by Biasutto et al………………………………………….………...39 
13. Resveratrol derivatives by Yang et al…………………………………………….…………40 
14. Mitsunobu reaction………………………………………………………………………….45 
15. By-product of Mitsunobu reaction………………………………………………………….52 
 
 
 
 
 11 
 
LIST OF ABBREVIATIONS 
DNA   Deoxyribonucleic acid 
RNA                 Ribonucleic acid 
Fig                    Figure 
UV                    Ultraviolet 
h                        Hours 
Rf                       Retention factor 
Rpm                   Rounds per minute 
Temp                 Temperature 
M.p                    Melting point 
TMS    Tetramethylsilane  
NMR                 Nuclear Magnetic Resonance 
Lit                     Literature 
THF                  Tetrahydrofuran 
Hex                   Hexane 
RV    Resveratrol 
 
 
 
 
 12 
 
 CHAPTER 1  
INTRODUCTION 
  Within the past few centuries, scientists have been able to extract important compounds 
with biological activities from plants. Scientists believed it was impossible to totally synthesize 
these complex molecules in the laboratory. They encountered difficulty in understanding the 
exact structure of these molecules in the first place, let alone attempt to synthesize them. With 
the advent of good electronics, scientists could deduce the exact structure of most natural 
compounds with biological activities. Hence they could synthesize these compounds and study 
their structure activity relationship (SAR). Resveratrol (RV) is a bioactive compound produced 
by some plants in response to pathogen attack or stress. This compound has received increased 
attention within the past decade and it was commercialized as a dietary supplement as a result of 
several health benefits that have been reported. Examples of such health benefits includes 
antifungal1, anti-cancer2, antibacterial3, inhibition of platelet aggregation4, just to name a few. RV 
is currently in clinical trial phase two as an anti-cancer agent for colon cancer5-7.  RV has shown 
anti-cancer activities that really attracted more researches to study it. However, there is a big 
setback associated with the health benefits of resveratrol; it has a low bioavailability. As a result, 
efforts to synthesize resveratrol derivatives with better bioavailability and hopefully 
improvement in some of its activities such as antioxidant activity, and anti-cancer activity were 
considered as objectives. This thesis discusses the biology of cancer, natural compounds with 
bioactivities, and details of the health benefits of resveratrol, and presents details of the design 
and synthesis of resveratrol derivatives. 
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Cancer 
Cancer is any malignant growth or tumor caused by uncontrolled cell growth.8  Normal 
cells grow, divide, and die in an orderly manner (apoptosis). During the early years of our life, 
normal cells grow rapidly, but as we approach adulthood, most cells divide to replace older ones. 
Cancer cells don’t die; they continue to grow, producing more abnormal cells. Cancer cells can 
travel to other parts of the body and grow into other tissues via blood and lymph, a process 
known as metastasis.  Normal cells become cancer cells as a result of damage to DNA. Mistakes 
during normal cell division usually give rise to cancer cells. There are two main causes of DNA 
damage, environmental and hereditary.   Cancer is a group of diseases that are usually named 
after the organ or tissue that it originates from; there are over 100 categories of cancer. 
Nomenclature and Types of Cancer 
Most cancers are named after the organ or region from which the originate .Below are 
some of the most popular cancer categories. 
Leukemia: This is cancer that originates from blood forming tissues, such as bone 
marrow, and causes large number of abnormal cells to be produced into the blood stream. 
Breast Cancer: This type of cancer usually originates from two tissues of the breast; tubes 
which carry milk to the nipples known as ducts and glands that make milk known as lobules. 
This type of cancer is common in both men and women; however, it is more frequent in females. 
Colon cancer: This type of cancer originates from tissues of the colon. The colon is the 
longest part of the large intestine. The most common type originates in the mucus making and 
releasing tissues know as adenocarcinomas. 
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           Kidney Cancer: Originates form kidney tissues, two main tissues are involved in this type 
of cancer; renal cell carcinomas which originates from the lining of small tubes (nephrons) that 
filter blood and remove toxins, and renal pelvis carcinomas which originate from the center of 
the kidney where urine collects. 
Lung Cancer:   Cancer that begins in long tissues and there are two main types namely 
small and non-small lung cancer. They differ based on how the appear under a microscope. 
Melanomas: Cancer that begins in melanocytes which are cells producing the pigment 
melanin. It can originate from the mole (skin melanoma) or from other pigmented tissue such as 
the eye and intestines. 
Prostate Cancer: This type of cancer originates from tissues of the prostate gland found in 
the male reproductive system. It is situated below the bladder in front of the rectum.  
Causes and Prevention of Cancer 
Cancer results from normal cells, which are programed to divide when they need to and 
die when the body does not need them or when they are instructed to die. Cancer may result 
when cells grow out of control or when they forget to die. They are several factors that may 
cause a cell to grow out of control, which are usually related to DNA damage, a few of them are 
listed below 
 Drinking excess alcohol 
 Exposure to excessive sunlight 
 Environmental toxins such as poisonous mushrooms 
 Benzene and other carcinogenic chemicals (polyaromatics) 
 15 
 
 Obesity 
 Radiation Exposure 
 Smoking 
 Viruses 
However, the cause of many cancers is still unknown. It is difficult to completely prevent cancer, 
but it is possible to reduce the risk of developing cancerous tumors. A few things to do in other 
to reduce risk of getting cancer is listed below 
 Eating a healthy diet. 
 Regular Exercising. 
 No smoking or chewing tobacco. 
 Minimizing exposure to radiation and toxic chemicals. 
 Maintaining a healthy weight. 
 Limiting alcohol consumption. 
 Reducing sunlight exposure especially if skin is susceptible to getting burns. 
In the Unites States, the most cancer-related deaths are due to lung cancer
12
. Lung cancer and 
colon cancer are most common amongst males and females, while prostate cancer is very 
common with men and breast cancer with females. 
34 
Treatment Options                                                                                                                                               
There are various treatment options that are currently being used to alleviate, treat, and control 
the symptoms of cancer. The most popular of these options will be discussed. 
Chemotherapy. This type of therapy involves the administration of medications that treat 
cancer. It is the mainstay treatment of malignancies and it dates back as early as 1900s when 
 16 
 
bone marrow suppression effect of nitrogen mustard was observed. It has evolved from relief of 
symptoms to cancer cure. Tumor cells reproduce at abnormally high rates compared to normal 
cells because their stop mechanism is faulty. Classic chemotherapy involves compounds that 
destroy RNA or DNA in cells. The more rapidly cells divide, the more effective these 
compounds perform their task of killing cells. The cell replication process consist of four phases; 
G1, S, G2,  and M phase which stands for  growth phase 1,  synthesis (DNA replication), growth 
phase 2, and mitosis respectively. Chemotherapy medications that kill cells at any of the above 
phases are referred to as cycle nonspecific, whereas those that kill cells in a specific phase are 
known as cycle specific. When a cell is not in any of the above phases, it is said to be in a resting 
phase denoted by Go. Medications can be administered orally (pill form), or injected directly into 
body cavity (bladder, abdominal cavity, or intra-arterially. Chemotherapy medications are 
usually administered as regimens. A regimen is a mixture of specific and nonspecific 
compounds. Chemotherapy is a systematic form of therapy because its effect is spread 
throughout the body. Chemo substances also kill normal cells in the body, thus the objective is to 
kill cancer cells and spare normal cells. It is important that traits specific to cancer cells be 
identified and chemo substances that target these cells are administered. Most chemo treatments 
target fast growing cells, unfortunately, there are also some fast growing normal cells and are 
thus killed as well. Hair follicles, skin, gastrointestinal track cells are victims as hair loss, rashes, 
and diarrhea respectively are common side effects of chemo.  There are different kinds of 
chemotherapy that include: alkylating agents, antimetabolites, anthracyclines, plant alkaloids, 
antitumor antibodies, taxanes, and monoclonal antibodies.  
Radiation Therapy. This is the use of high energy X-rays to kill cancer cells. It is a form 
of local therapy because it is region specific.  There are two modes of application, externally or 
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internally. External radiation, the cancer region is exposed to X-ray from outside the body; it is 
also referred to as X-ray therapy. For internal radiation therapy, the source of radiation is 
surgically placed inside the body near the tumor. Such sources include Radium, Cesium, Iodine 
and Phosphorous.  It is also known as Brachy or implant. 
Surgical Oncology. This involves the surgical treatment of a variety of tumors. In 1809, 
Ephrain Mcdowell first reported resection of an ovarian tumor. However, ancient Egyptians 
described techniques for removing breast tumors back in the 7
th
 century. Surgical Oncology is 
the oldest from of cancer treatment. 
Bioactive Natural Products 
These are chemical compounds in living organisms that exert a biological effect on other 
organisms. Such biological effects includes: therapeutic activity on other organisms, toxic 
activity that causes disease and biodegradable toxicity.  The use of herbal and other natural 
medicine has a long history.  Herbal medicine involves either the use of a whole plant or crude 
preparations for therapeutic and experimental reasons. This method of administration poses a 
number of disadvantages outlined below. 
 Variation in the amount of active components with region. This is as a result of 
season, plant parts, morphology, climate, and ecological aspects. 
 The presence of undesirable compounds that can cause drug synergistic, 
antagonistic, and unpredictable modulations of bioactivity.  
 Changes or lose of bioactivity of the herbs due to variability in collection, storage, 
and preparation of the raw material. 
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As a result, isolation of bioactive natural products is essential to combat the above cons. Some 
advantages of isolation of bioactive products include: 
 The administration of pure bioactive compounds is possible in reproducible and 
accurate doses.  
 Development of analytical assays 
 Because bioactive compounds are isolated, their structure can be determined. This 
will spur synthesis production, incorporation of structure modification, and 
rationalization of mechanisms of action. 
 Reduced dependency on plants and saving the environment. 
 Investigation of structure/activity relationship is facilitated. 
 Development of new compounds with similar or more desirable bioactivities. 
A very broad range of natural products has been identified, extracted, and synthesized within the 
last century; this established the basis of the pharmacological industry and drug discovery. This 
dependency on natural products is evident; approximately 60% of anticancer compounds and 
70% of drugs for infectious diseases are natural products or their derivatives 9. Natural products 
can be classified according to their sources. There are four main sources of natural products; 
plant kingdom, marine world, animal sources, and microbial world. 
Plant kingdom 
The plant kingdom is a very rich source of lead compounds.  Examples include alkaloids, 
morphine, cocaine, digitalis, tubocurarine, quinine, nicotine, and muscarine. Some of these lead 
compounds are drugs themselves such as alkaloids, morphine, and cocaine10. Compounds 
derived from the plant kingdom forms the basis for synthetic drugs, such as local anaesthetics 
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developed from cocaine. A clinically useful drug isolated from the Yew tree is paclitaxel (brand 
name Taxol)  a very effective anticancer agent9. An antimalarial agent called artemisinin has 
been isolated from Artemisia annua. The plant kingdom provides a large source of rich, 
complex, and highly diverse structures, some of which are unlikely to be synthesized in the 
laboratory.  Studies of plants revealed that they produce protective compounds to deter animals 
and microbes. These types of compounds are classified as phytoalexin11-15. Resveratrol is one of 
such compounds produced by the skin of grapes and certain plants. There are over 300,000 
species of higher plants 9, about 1% have been used for food of which about 150 species is 
commercially cultivated. About 10,000 plant species have documented medicinal use. This still 
represents a very small percentage of higher plants. Thus, there are potentially more important 
compounds in plant species that could have pharmacological applications that are yet to be 
discovered. 
Microbial World                                                                                                                                                           
Microbial world represents organisms that are unicellular or live in a colony of cells. 
They are also known as microbes and include bacteria and fungi10. These organisms are 
invaluable for discovery of drugs and have been a reliable source of lead compounds. Microbes 
produce a large variety of anti-microbial agents, which have evolved to give their host an 
advantage over their competitors.  The discovery of penicillin by Alexander Fleming in 1928 
motivated the screening of soil and water samples for new microbes and strains. This became 
highly popular, and as a result and an impressive arsenal of antibacterial agents were discovered. 
This includes cephalosporins, tetracycline, aminoglycosides, rifamycinsl, and chloramphenicol. 
A significant number of drugs derived from microbes are used as antibacterial agents. Microbial 
metabolites have also contributed to the medicinal world. Some metabolites have provided lead 
 20 
 
compounds; example is asperlicin which was isolated from Aspergillus alliaceus. Lovastin (a 
fungal metabolite) was a lead compound in a drug series that lowers cholesterol levels. 
Cyclosporine suppresses immune response after organ transplant operations. Thus the microbial 
world has been very useful in the medicinal world 
Marine World                                                                                                                                                                  
In recent years, great interest has been developed to explore the potentials of organism 
living in the marine world as a source of bioactive compounds as drugs or lead compounds. 
Marine sources include coral, sponges, marine microbes, and fish. Bioactive compounds with 
inflammatory, antiviral, and anticancer properties are common. Curacin A obtained from 
cyanobacteria exhibits antitumor activity. Other examples include eleutrherobin, discodermolide, 
bryostatins, dolostatins, and cephalostatins. 
Animal Sources 
Animals have sometimes been an important source of new drugs or lead compounds. A 
series of antibiotic peptides have been extracted and isolated from the skin of an African claired 
dog.  A very potent analgesic compound called epibatidine has been isolated from the 
Ecuadorian poison frog. 
Antioxidants 
An antioxidant, as the name implies, is a molecule that has the ability of inhibiting the 
oxidation of other molecules. Oxidation is the transfer of electrons or hydrogens to an oxidizing 
agent. Oxidation processes can produce free radicals that in turn can start chain reactions. In 
biological tissues, biochemical reactions related to infections, exposure to radiation, and energy 
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production processes are examples of processes that generate free radicals 1, 16-18. Free radicals are 
thus naturally generated in the form of endogenous reactive species 19. There are two types of 
reactive species, reactive oxygen species (ROS) and reactive nitrogen species (RNS). Reactive 
oxygen species include hydroxyl radical (HO
.
), superoxide (O2
.-
), hypochlorite ion (ClO
-
), 
hydrogen peroxide (H2O2), singlet oxygen (
1
O2), and peroxyl radical.  RNS includes nitric oxide 
(NO) and peroxynitire (ONOO
-
), the latter is formed when NO reacts with superoxide.  
Antioxidants inhibit the oxidation of other molecules by getting oxidized themselves; 
they are thus reducing agents such as thiols, ascorbic acid, and polyphenols. These species are 
very reactive and are associated to a very short life time that rangers from 10
-9
 – 10-1s. The 
hydroxyl radical (HO
-1
) has the shortest lifetime of 10
-9
s and is the most reactive 20. These 
species react via three major pathways; radical transfer, charge transfer, and recombination. Our 
body has a natural antioxidant enzymatic system that involves enzymes like superoxide 
dismutase (SOD), catalases, and peroxidase. These enzymes control the concentration of these 
species (production and destruction) by acting in synergy with dietary antioxidants such as 
vitamin C, vitamin E, β-carotene, and gluthathione.19 There is a number of factors that may 
induce excessive production of these species such that the natural control process becomes 
rapidly inefficient and leads to a condition called oxidative stress. Oxidative stress is a 
physiological condition in which there is an imbalance between production and manifestation of 
ROS and RNS and the body’s natural system to control their concentrations 16, 19, 20. Such factors 
include exposure to UV radiation, pollution, smoking, alcohol, and other chemicals. Oxidative 
stress leads to lipid peroxidation and as a result rapid cell structural damage, tissue injury, and 
gene mutation follows. This ultimately leads to development of various health disorders; 
Alzheimer’s disease, cancer, atherosclerosis, diabetes mellitus, hypertension, and ageing.17, 18, 20, 21 
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Antioxidants are classified according to their solubility; water soluble (hydrophilic) that 
reacts with oxidants in cytosol and blood plasma and lipid soluble (hydrophobic) that protects 
cell membranes from lipid peroxidation. Antioxidants function in three ways 
 Getting oxidized by reactive species 
 Chelating transition metals and prevents them from catalyzing the production of 
free radicals in cells 
 Sequestration of iron. This involves iron binding proteins such as transferrin and 
ferritin. 
The plant kingdom is an invaluable source of antioxidants 17, the most popular of which is 
a group of compounds referred to as polyphenols (flavonoids and proanthocyanidins). Phenolic 
antioxidants have been recognized as an important class of food ingredients as additives or novel 
ingredients to introduce extra health benefits. 18 The next section examines examples of 
polyphenols in terms of their properties, classes, and sources. 
Phenolic Compounds and Polyphenols 
Phenolic compounds are those that have one or more hydroxyl groups attached directly to 
an aromatic ring.  However, polyphenols are those compounds that have more than one phenolic 
hydroxyl group attached to one or more benzene rings. Polyphenols represents a large group of 
diverse chemical compounds. Polyphenols can be classified into several structural classes of 
which a few are outlined below. 
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Simple Phenolic 
These are hydroxyl substituted phenols at the othro, Meta, or para positions. Examples 
include Resorcinol ( 1,3-dihydroxylbenzen) and phyloroglucinol( 1,3,5-trihydroxybenzene).            
                                                           
Fig 1. Structure of simple phenolic 
Cinnamic acids 
 This class of polyphenols is derivatives of cinnamic acid; examples are caffeic acid and 
sinapic acid, Fig. 2 
                   
 
Fig 2. Structure of selected cinnamic acids and flavones 
 24 
 
Flavones 
In addition to the ketone group, a hydroxyl group is present. They are also known as 
dihydroxflavonols. A good example is taxiflolin that occurs naturally in association with tannins 
in heartwood, Fig 2. 
Napthaquinones and Anthraquinone 
Napthaquinones are very rare polyphenols of which juglone is the most popular and has 
been well studied. Anthraquinones are found in walnut; a good example is emodin Fig 3. 
 
Fig 3. Structure of  napthaquinones 
Stilbene and its Derivatives 
Stilbene is 1,2-diphenylethylene that is a highly conjugated compound. It exists as the 
trans and cis isomers of which the latter is thermodynamically less stable due to steric 
interactions with the two phenyl rings. 
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Fig 4. Structure of cis and trans stilbene 
Isomerism 
The trans isomer, (E)-1,2-diphenylethene is a solid that melts around 120 
⁰
C and is 
thermodynamically stable (Fig 4). Other names includes, (E)-Stilbene, trans-stilbene, and trans-
1,2-diphenylethene. Cis Isomer :(Z)-1,2-diphenlyethene  is a liquid that is thermodynamically  
less stable (Fig 4) due to steric interactions involving the aromatic rings  that forces them  out of 
plane and prevents conjugation. Other names include (Z)-Stilbene and cis-1,2-diphenyl ethane. 
Stilbene is used in the manufacture of dyes and optical brighteners, gain medium in dye lasers, 
and scintillator. The Z-isomer is widely used in the study of electrocyclic reactions. 
Derivatives of Stilbene  
Any compound that contains the stilbene skeleton is considered a derivative of stilbene. 
Generally, all compounds produced by plants containing the stilbene skeleton are referred to as 
stilbenes. One of the most common class of stilbenes produces by plants is known as stilbeniods. 
Stilbeniods are hyroxylated derivatives of stilbenes. Stilbeniods are a small class of compounds 
that belong to a family of phenylpropanoids. Phenylpropanoids are compounds synthesized by 
plants from amino-acid phenylalanine. Stilbeniods are produced by plants in response to 
pathogen infection or stress and are thus called phtoalexins. Phytoalexins are compounds 
produced by some plants in response to infections or stress. Examples include piceatonol, 
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pinosylvin, resveratrol, and its cousin pterostilbene . Piceatonol, pinosylvin, and pterosilbene are 
discussed briefly below, while resveratrol is discussed in great details later. 
Piceatonnol.5-[(E)-2-(3,'-dihydroxyphenyl)vinyl]benzene-1,3-diol, also called 3',4',3,5-
tetrahydroxy-trans-stilbene,  is a natural occurring metabolite of resveratrol previously identified 
as the active ingredient in herbal preparations in folk medicine.  It is present in rhubarb, berries, 
peanuts, sugar cane, wine, and skins of grape.   It is an inhibitor of protein tyrosine kinase
16, 17
, 
and other enzymes. Recent studies show that it inhibits gastric H
+
, K
+
-ATpase Enzyme 22
 
. It also 
exhibits strong antioxidant and antilukaemic activities due to the presence of the catechol moiety. 
 
 
Fig 5. Structure of piceatonnol 
Pinosylvin.5-[(E)-2-phenylethenyl]benzene-1,3-diol is a pre-infectious stilbenoid present 
in heartwood (Pinus densiflora) and leaf of pine (pinus densiflora) 23.  It is produced prior to 
infection and is thus referred to as a pre-infectious stilbeniod. It protects the woods from fungal 
infections. Pinosylvin possesses antibacterial and antifungal activities when tested with 
Staphylococcus aureus and Escherichia coli and also inhibits yeast growth.  
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Fig 6. Structure of pinosylvin 
Pterostilbene. 4-[(E)-2-(3,5-Dimethoxyphenyl)ethenyl]phenol  is a stilbenoid that was 
initially isolated from sandalwood tree. It is chemically related to resveratrol and is present in 
blueberries and the skin of grapes just like RV24.  Animal studies reveal anti-cancer, anti-
hypercholesterolemia, anti-hypertriglyceridemia, and anti-diabetic properties and its ability to 
fight and reverse cognitive decline. Pterostilbene possesses a higher bioavailability when 
compared to resveratrol and as a result it is easily transported into cells, more resistant to 
degradation and elimination.  It also possesses strong anti-oxidant properties thought to be 
through modulation of gene expression and enzyme activity. Beneficial effects on cognitive and 
neuronal function during aging have been observed. Anti-inflammatory, anti-neoplastic, 
antifungal and anti-viral activities have also been reported. 
 
Fig 7. Structure of pterostilbene 
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Resveratrol 
Resveratrol is a natural polyphenol produced by some plants, and it possesses several 
biological activities that have been exploited in recent years. The research efforts of this thesis 
are to synthesize new derivatives of RV so as to enhance some of their biological activities. It is 
thus important to outline the characteristics of this compound, its history, sources, biological 
activities, synthesis, and chemical and physical properties. The next section discusses most of the 
aspects of resveratrol mentioned above.                                                                                                                                        
Nomenclature and Structure 
The structural formula of RV is shown in Fig. 7, including the numbering of the carbon 
atoms according to IUPAC. Other names includes trans-3,5,4'-trihydroxystilbene,  3,4',5-
stilbenetriol,  and trans-resveratrol. 
                                                    
Fig 8. Structure of resveratrol, IUPAC numbering giving. 
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Isomerism 
RV exists as two isomers, the cis and the trans isomers, Fig.8. The trans isomer is 
thermodynamically more stable just like the trans stilbene. The Cis isomer is thermodynamically 
less stable due to steric interactions that forces the phenyl rings out of plane and prevents proper 
conjugation. However, the Cis isomer possesses antioxidant and anti-inflammatory properties but 
has not been thoroughly studied. 
 
Fig 9. Structure of RV isomers 
Chemical and Physical Properties 
RV is a white powder with a slightly yellow cast and very low water solubility (0.03g/L). 
However, it is more soluble in DMSO and ethanol, 16 g/L, and 50 g/L respectively. RV is a 
derivative of stilbene and thus exists in cis and trans forms of which the trans is most stable. The 
trans form can undergo isomerization to the cis form upon exposure to UV light. RV has the 
phenol unit and will thus undergo most chemical reactions of phenols such as oxidation. RV 
shows anti-oxidant properties and thus easily oxidized. 
History and Sources 
Resveratrol (RV) was first isolated in 1940 as an ingredient of the roots of white 
hellebore (Veratrum gradiflorum O. Loes)25. In 1963, it was identified as the active ingredient in 
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dried roots of Polygonum cuspidatum also referred to as Ko-jo-kon in Japanese. RV was first 
detected in grape vines in 1972 and wine in 199225-28. It was detected in grape skin especially 
when infected with Botrytis cinerea. RV is synthesized in leaf epidermis and grape skin. Fresh 
grape skin contains about 50-100 mg per g of dry weight. The concentration of RV in red wine 
ranges from 2-40μM. RV is present in peanut butter and many types of berries2, 8, 29-31 
The French Paradox 
Within the past few decades, the French population has been identified as a regular 
consumer of red wine. The so called ‘French Paradox’ is the low prevalence of coronary heart 
disease related death in the French population compared to the rest of Europe  despite high intake 
to dietary cholesterol and saturated fats11, 12, 25, 32. The incidence of heart infarction in France is 
about 40% lower than the rest of Europe.25. Epidemiological Studies reveal an inverse 
relationship between the consumption of wine and the incidence of heart infarction25. All these 
observations led to the suggestion that RV might be the active ingredient in red wine responsible 
for cardio protection.  
Reactivity  
The stilbene skeleton is stable and the reactivity is associated with the hydroxyl 
functional group of the phenol units.  RV is a good radical scavenger through electron capture or 
proton donation to convert free radicals to more stable molecules. From the structure of RV, the 
OH-group at the 4’-position is more acidic compared to the 3 and 5 position. Schemes 1  and  2  
show the resonance strutures involved with proton abstraction at the 4’-postion and 3-position 
respectively. The 3-position and 5-position are equivalent due to rotation of the sigma bond 
between carbon-1 and the SP
2
 hybrized carbon on the structure of RV. 
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Scheme 1.  Resonance structures from proton abstraction at 4’-hyroxyl group 
Dietary supplement 
RV has been shown to have many health benefits and has been available as a dietary 
supplement within the past 10 years
21
. Extensive media coverage greatly increased the sales of 
RV in 2006 although studies presented the fact that benefits to humans are yet to be proven
27
. 
Many kinds of supplements are available in the market today and vary in terms of purity (50 to 
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99%). Many brands are unpurified extracts from Japanese knotweed tree, which also contains 
emodin
16 
 
 
Scheme 2. Resonance structures from proton abstraction at 3 or 5-hydroxyl group.  
Reported Biological Activities 
On the basis that RV is a phytoalexin and strong antioxidant, it has been subjected to a 
several pharmacological studies, and several biological activities have been reported. This 
includes antioxidant1, 16, 33-35, coronary  vasodilator, inhibitor of platelet aggregation, 
cardioprotective, anti-microbial, anti-fungal, anti-leukaemic, anti-diabetic, anti-inflammatory36, 
cancer chemo-protective15, 26, 29 , anti-tumor29, 31, anti-aging37, 38, and several unreported biological 
studies. However, most of the biological activities of RV have been observed by in vitro studies 
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and more in vivo studies are in progress. This has led to increased interest in RV related 
research. 
Recent Applications 
In 2010, Kanti et al. explained the biological effects of RV are due to its anti-oxidant 
activities. In their review on the anti-oxidative activity of RV, they identified all studies relating 
to the anti-oxidant activity of RV and linked it with some biological activities. For example, 
based on a study that RV prevented formation of membrane protein carbonyls (PCO) in red 
blood cells and plasma under oxidative stress conditions, it is clear that RV prevents protein 
oxidation because PCO are products of protein oxidation. Also, based a study that confirmed the 
presence of PCO in artery plaque, Kanti et al. concluded that the prevention of coronary heart 
disease by resveratrol was due to its anti-oxidant activity. 
In May 2011, Kumerz et al. discovered that RV had the potential to prevent migration of 
vascular smooth muscle cells (VSMC). Migration of VSMC can be induced by platelet-derived 
growth factor (PDGF), the wound healing process, or by Epidermal Growth factor (EGF). This 
migration is believed to be mediated by the Rac Activation. In their study, they found out that 
RV (50μM) reduced the migration of VSMC due to EGF but not PDGF32  
Biosynthesis of Resveratrol 
In biosystems, RV is synthesized through the same pathway as chalcone and Quercetin. 
All plants have the substrates (4-courmaroyl-CoA and Malonyl-CoA) necessary for the synthesis 
of resveratrol but lack the enzyme stilbene synthase (STS), a key enzyme in the synthesis.  
Scheme 3 shows the synthetic pathway in which 4-courmaroyl-CoA is used to perform three 
condensation reactions with Malonyl-CoA. 
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Scheme 3.   Biosynthetic pathway of resveratrol 
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Chemical Synthesis of Resveratrol 
RV has been extracted from plants; however, extraction processes are associated with 
high cost and low purity and thus a need for total synthesis of RV. Several synthetic pathways 
have been used to synthesized RV including the Wittig reaction, vinylsilane Heck reaction, and 
Optimized Horner –Emmons reaction. The reaction scheme for the last two synthetic pathways 
are shown below 
 
Scheme 4.  Vinylsilane Heck Reaction for synthesis of  RV 
 
Scheme 5.  Optimized Horner-Emmons synthesis of  RV 
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Pharmacokinetics 
Several in vivo studies in animals and humans reveal that intestinal uptake of RV is very 
low25
,39. There are only trace amounts in the blood stream due to extensive metabolism in the gut 
and liver. Oral administration and intravenous injection of RV is rapidly metabolized within 2 h 
reaching a peak at about 30mins40. The bulk of the RV is converted to sulfate and glucuronide 
substrates25.  As a result of this fast metabolism, it has been suggested that the biological effects 
of RV might be associated with its metabolites or could act in synergy with other polyphenols25. 
In humans, most of RV administered intravenously is metabolized to the sulfate conjugate within 
≈30 mins. The scheme below shows the proposed metabolic pathway of RV in human cytosol in 
vitro. Human recombinant sulfortransferases (SULTs) are involved in the catalysis. 
 
Scheme 6.  Proposed metabolic pathway of RV in human liver cytosol in vitro 
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Interesting Resveratrol Analogues 
Within the past few years, several resveratrol analogues have been synthesized and 
subjected to biological evaluation. Some very interesting results have been reported in which 
certain biological activities of the new analogues were better than RV. There are two main 
designs involved in the synthesis, conservation of the stilbene skeleton and modification of the 
skeleton by adding a nitrogen or sulfur in one or both rings. Three examples are discussed in this 
thesis, one for modification of the skeleton and two in which the stilbene skeleton is conserved. 
In 2005, Chen et al.36 synthesized and evaluated the anti-inflammatory activity 17 novel 
resveratrol derivatives on xylene-induced mouse ear edema. The pharmacological results showed 
that some compounds have potent anti-inflammatory activities. Compounds 3a and 4b below 
showed an edema reduction ranging from 30 to 35%. 
 
Fig 10. Structure of selected analogues by Chen et al 
In 2008, Jiang38 designed, synthesized, and did spectroscopic studies of resveratrol 
aliphatic acid ligands of human serum albumin (HSA). HSA is the most abundant serum protein 
in humans produced in the liver and has a life span up to 20 days.  Jiang synthesized both 
aliphatic esters and aliphatic acids. The acids showed better solubility in pure water and 
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phosphate buffer (pH 7). Compound 4 in figure below was found to be a much better ligand for 
HSA than resveratrol and hence 5 should bound tightly to HSA.  
 
Fig 11. Resveratrol derivatives by Jiang 
In 2009, Jiang et al.5  further investigated the role of compound 3 and 4 in Toll-like 
receptor 2(TLR2)-mediated apoptosis. TLR2 are involved in innate immune system (non –
specific immune system) and function to recognize pathogens, and thus aimed at defending the 
host. TLR recognizes and responds to pathogens in a generic way. They reported that compound 
4 significantly inhibits the expression of TLR2 and also overexpression of TLR2 in human 
embryonic kidney (HEK293) cells caused significant decrease in apoptosis after treatment with 
compound 4. 
Recently, Biasutto et al.41 added glucosyl groups to the RV preserving the stilbene 
skeleton (Fig 11). When administered to rats, its blood concentration versus time curve shifted 
towards longer times compared to resveratrol. However, these derivatives were destroyed by 
blood esterases in less than 1 h. The compound was found to be water soluble and nearly stable 
in acidic environments similar to the stomach. 
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Fig 12. Resveratrol derivative by Biasutto et al. (3’,4’,5-tri(α-D-glucose-3-succinyl) 
In 2007, Yang et al.37 published in Aging Cell, a series of compounds that could extend 
yeast replicative lifespan. In is known that dietary restriction (DR) delays aging and extends the 
maximum lifespan of a wide range of organisms. In mammals, DR delays numerous age-
associated diseases including cancer, neurodegeneration, atherosclerosis, and type II diabeters. 
An active area of research is the search for small molecule mimetics that can deliver the health 
benefits of DR.  Since the identification of members of the family of Surtuin genes (SIRT2, 
SIR2L1, SIR2α) it has been hypnotized that they play a key role in an organism’s response to 
stress and also responsible for the life-extension benefits of DR. It has been observed that 
increased expression of the SIR2 gene in many simple organisms is associated to 30-50% life 
extension42, 43. Yang et al. designed synthesis routes in which the stilbene skeleton was preserved 
as well as the 3 and 5 hydroxyl groups and modified the 4’-hyroxyl group by substituting the 
proton with thiomethyl, methyl, ethyl, methoxy, and acetoxy groups, Fig.12. Their design was 
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based on previous structure-acitvity relationship of SIRT1 activation by stilbenes from plant 
sources. 
 
Fig 13.  Derivatives by Yang et al 
Compound 1 above was the most effective at stimulating SIRT1 with 18-fold increase in 
activation. RV, 2, 3, and 4 activated SIRT1 12-fold, 16-fold, 14-fold, and 11-fold respectively. 
Also, compounds 1, 3, and 4 extended the mean and maximum yeast life span. 
Drawbacks of Resveratrol 
The main drawback of resveratrol is its low bioavailability. Bioavailability is broadly 
defined as the absorption and use of a nutrient 40. The low bioavailability of RV is associated to 
its fast metabolism in the liver and gut and also its low serum solubility.  Also, most in vivo 
studies involve administration of high doses of RV that could be toxic to cells. Hence the 
cytotoxicity of RV needs to be investigated properly. 
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Objectives of Research 
The main objectives of this research are to design and synthesize new resveratrol esters 
and acids derivatives to improve water solubility, serum transport by HSA, anti-cancer activity, 
and other biological activities. Another objective of this research is to carry out independent 
organic synthesis and structure elucidation of such compounds by spectral analysis. 
Synthesis Design 
The types of RV derivatives to be synthesized were motivated by results reported by 
Jiang et al.
38
 They reported increased binding of long chain RV ester derivatives to HSA and 
increase water solubility of RV aliphatic acids. Three methods were designed to synthesized RV 
esters and one for total synthesis of RV aliphatic acids. Generally, all the designs conserve the 
stilbene skeleton, and modifications where made on the hydroxyl groups. Scheme 7 below shows 
the types of derivatives to be synthesized.  
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Scheme 7.  Synthesis Design for RV Esters 
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Method A 
This method is designed to synthesize tri-esters such that all the hydroxyl groups undergo 
esterification. The objective is to have the same ester chain. This can easily be achieved by 
reacting RV with acid chlorides in the presence of a base. 
Method B 
This method is designed to synthesize di-esters at the 3 and 5-hydroxyl positions leaving 
the 4’-hydroxyl group available.  This type of ester is designed as a precursor for synthesis of 
mixed ethers. This conversion can be achieved by subjecting a tri-ester to a regiospecific lipase 
enzyme to preferentially hydrolyze the 4’ position. 
Method C 
 This method is designed to synthesized mixed esters by esterification of 4’-hydroxyl 
group while the 3 and 5-hydroxyl groups have already by esterified. A  Mitsunobu reaction is 
employed to achieve the target compounds 
Total Synthesis of Resveratrol Aliphatic Acid 
 Jiang et al.
38
 reported the increased water solubility of RV aliphatic acids, thus, a 
different type of aliphatic acid similar to that which they synthesized could have better biological 
evaluation data. The design for total synthesis is shown in the scheme below. It generally 
involves synthesis of esters followed by hydrolysis, scheme 8. 
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Scheme 8. Synthesis of resveratrol aliphatic acid 
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The Mitsunobu Reaction 
This reaction was discovered by Oyo Mitsunobu (shown below); it converts an alcohol 
into a variety of functional groups such as esters using triphenylphosphine and an 
azodicarboxylate such as diethyl azodicarboxylate (DEAD).  This reaction requires an acidic 
nucleophile because DEAD must be protonated during the reaction; typically, the nucleophile 
must have a pKa lower than 15. The reaction proceeds with inversion of configuration on the 
alcohol carbon as shown on the scheme below. The order of addition of reagents is crucial, 
typically the alcohol, acidic nucleophile, triphenylphosphine are dissolved in THF, then DEAD 
added slowly to the mixture and stirred for about 12 h. 
 
 
Fig 14.  Mitsunobu reaction 
Example of Mitsunobu Reaction 
Bruno et al. in 1997 made use of the Mitsunobu reaction to synthesize functionalized 
aromatic oligomers 44. A phenol functional group was used as the acidic nucleophile and 2-(2-
hydroxyethyl) pyridine as the primary alcohol to afford the desired product in high yield (84%). 
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Scheme 9. Mitsunobu reaction by Bruno et al. 
 
Mechanism of Mitsunobu reaction 
There has been much debate on the intermediates involved in the Mitsunobu reaction, and 
it has been a long debate. Generally, the phosphine makes a nucleophilic attach on DEAD to 
form betaine intermediate that abstracts a proton from the acidic nucleophile to form an ionic 
intermediate. The DEAD abstracts a proton from the alcohol resulting in the production of the 
oxyphosphonium ion and a diamide by-product. The nucleophile then attacks the 
oxyphosphonium ion to form the product and triphenyloxide. The scheme below shows the 
detailed mechanism. 
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Scheme 10.  Mechanism of Mitsunobu reaction 
  
Proposed Synthetic Pathway for Compound 2 and 4 
Compounds 2 and 3 have been synthesized before; they are to be used as precursors for 
compound 5. 
 
Scheme 11.  Synthesis of tri and di acetyl esters of RV. 
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Proposed Synthetic Pathway for Compound 3 
 
Scheme 12. Synthesis of long chain tri-ester of RV 
 
 
Proposed Synthetic Pathway for Compound 5 
 
Scheme 13. Mitsunobu Reaction for synthesis of 5 
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Proposed Synthetic Pathway for Compound 9 
 
Scheme 14. Hydrolysis of ester to acid 
 
Proposed Synthetic Pathway for compound 6 
 
Scheme 15. Mitsunobu Reaction with 2’, 3’-di-O-Acetyl adenosine 
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CHAPTER 2 
 
RESULTS AND DISCUSSION 
 
Synthesis of 3,4’,5-triacetyloxystilbene, 2 
 
 
 
Compound 2 was obtained as a white solid after recrystallization from a 1: 1 
hexane/acetone solvent mixture with Mp 120-121 ⁰C (lit 121-122) ⁰C. This compound has been 
synthesized before and was used as a precursor in the proposed synthetic pathway. A yield of 
74% was obtained versus 94% reported in lit
45
. The triethylamine reacts with the acetyl chloride 
to produce a salt which is a stronger electrophile and will be attacked by the hydroxyl groups of 
RV according to their acidity starting with the 4’-hyroxyl group. 
 
Synthesis of methyl 1,1’,1’’-(3,4’,5-stilbenyl)-1,6-hexanedioate, 3 
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Compound 3 was obtained in high yield (88%) as a dense colorless liquid. 
1
H NMR was 
very clean and purity above 95% was calculated based on the ratio of the most intense peak and 
sum of impurity peaks. This is a new compound and will be subjected to biological evaluation. 
Synthesis of 3,5-diacetyloxystilbene, 4 
 
 
 
Compound 4 was obtained as a white solid after recrystallization from hexane/acetone 
(4:1, v/v) Compound 2 was subjected to enzymatic alcoholysis with lipase Antarctica which is 
regiospecific to the 4’ position. The overall yield of the above reaction was up to 95% as the 
starting material could be recovered and subjected to further hydrolysis. However, the reaction 
yield for single enzymatic alcoholysis was 18% compared to 25% reported in lit. Compound 4 
was synthesized as a precursor to compound 5. 
 
Synthesis of methyl 8-(3’,5’-diacetyloxystilbene-4”-oxy)-3,6-dioxooctanate, 5 
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Compound 4 was subjected to the Mitsubonu reaction to serve as the acid to yield 
compound 5 as a greasy brown oil. However, both 
1
H NMR and 
13
C NMR revealed the presence 
of a by-product of the Mitsubonu reaction that appears to be closely associated to compound 4. 
Several purification attempts did not remove the impurity; however, the amount of impurity was 
reduced to obtain 4 with about 90% purity. The impurity was identified as the structure in Fig 
below. 
 
Fig 15. By-product of Mitsunobu reaction 
 
 
Synthesis of 8-(3’5’-dihydroxystilbene-4”-oxy)-3,6-dioxooctanoic acid, 9 
 
 
 
Compound 9 was obtained as a brown solid, 43.6% yield. However, 
1
H NMR spectra 
reveal the presence of the same impurity that was present in 5. Attempt to further purify it 
involved further hydrolysis with a strong base, KOH, for two days and column purification 
hoping that all the by-products will be hydrolyzed. But the impurity was still present, leaving the 
compound only about 90% pure. 
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Synthesis of 4’-(2’,3’-di-O-acetyladenosine)-3,5-Di-O-acetylstilbene, 6 
 
 
Compound 6 was obtained as a white solid. However, the 
1
H NMR spectrum was not 
good. Compound 6 was very basic and difficult to separate from starting material, even after 
several column purification with different solvent systems. Further work on this compound was 
abandoned. 
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Conclusions 
The objectives of this research were fulfilled with the synthesis of new RV esters (3, 5, 
and 6) and aliphatic acid (9) derivatives. However, only one of these new compounds (3) is good 
enough for publication per Journal of American Chemical Society, and can be subjected to 
biological evaluation because it was obtained in high purity and yield. Compounds 2 and 4 have 
been synthesized before; however, they were not subjected to biological evaluation. Hence, they 
can be subjected to biological evaluation 
Method A 
This method was designed to synthesize tri-esters of RV by esterification of the three 
hydroxyl groups of RV.  Acid chlorides were used because they are more reactive than the 
corresponding carboxylic acid. A new compound, 3 was obtained through this method in high 
yield and purity. This compound is a good candidate for biological testing and could have better 
bioavailability compared to RV. The long hydrophobic chain and hydrophilic heads could be 
very interesting.  A similar kind of triester had been synthesized before and biological evaluation 
revealed it had better bioavailability41 than RV.  The Purity of 3 was determined to be more that 
95% pure based on 
1
H NMR integration. Compound 2, which had been synthesized before, was 
obtained thorough this method as a precursor that was used for total synthesis of the aliphatic 
acid. 
Method B 
This method was designed to synthesize di-esters of RV with esterification at the 3 and 5-
hydroxyl group. Compound 4 obtained through this method and used as a precursor to compound 
5 and 6. The synthesis of this compound involves enzymatic hydrolysis of compound 2 using 
lipase Antarctica that was selective for hydrolysis at the 4’-position. A yield of 22% (lit. 60%45 
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30%46) was obtained and starting material was recovered and reused. For future work, this 
conversion can be increased to 94% by using a different lipase enzyme, P.cepacia lipase 46. 
Method C 
This method was designed to obtained long chains of esters at the 4’-postion. Two mixed 
esters were obtained through the Mitsunobu reaction of compound 4 to afford compounds 5 and 
6.  These two compounds were associated to impurities that could not be completely removed 
and purity was accessed to be below 90%. Future work will involve improving the purity of the 
compounds by trying out different reactions schemes to synthesize the compounds. 
Total Synthesis of RV aliphatic acid 
Compound 9 was obtained by hydrolysis of 5. However, the same impurity present in 
compound 5, which was identified to be the by-product of the Mitsunobu reaction, was present. 
Further hydrolysis for 2-days in an attempt to hydrolyze the product was attempted, but still final 
compound was only about 90% pure. Future work will involve synthesizing the compound 
through a method that high purity can be achieved. 
  A new RV triester has been synthesized in high yield and purity and would be subjected 
to biological evaluation in future work.  Future work will involve synthesis of the di- and mono-
ester derivatives by enzymatic hydrolysis and Mitsunobu reaction respectively.   
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CHAPTER 3 
EXPERIMENTAL 
General Methods 
All commercial reagents including RV were purchased from Sigma (St.Louis, MO, USA) 
and used without further purification. Solvents were distilled when necessary and mentioned in 
the experimental procedures. All proton (
1
H) and carbon (
13
C) NMR spectra were recorded on 
JEOL-NMR Eclipse spectrometer operating at 400 MHz.  Chemical shifts were recorded as delta 
values in parts per million (ppm) relative to TMS. The multiplicity of signals is reported as 
follows: s, singlet; d, doublet; m, multiplet. Column chromatograph was performed using silica 
gel as stationary phase and different mixtures of solvents as eluents. Thin layer chromatography 
(TLC) was performed on silica gel plates using appropriate solvents and visualized under a 
UVGL-58 UV lamp using short wave.  All weighings were done using Adventurer Pro mass 
scale. Melting points were determined using MEL-TEMP and recorded without correction. 
 
Experimental Procedures 
Synthesis of 3,4’,5-triacetyloxystilbene, 2 
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 To a one-neck 50 ml-round-bottomed flask were added resveratrol (0.60 g, 2.63 mmol), 
acetone (20 mL), acetyl chloride (0.561 mL, 7.89 mmol), and triethylamine (1.096 mL, 7.89 
mmol). The mixture was stirred (350 rpm) at r.t for 16 h. The mixture was acidified using 2N 
HCl. The resulting mixture was extracted with ethyl acetate (2 × 20 mL), washed with a 
saturated solution of sodium bicarbonate (3× 10 mL), and dried with anhydrous magnesium 
sulfate. The magnesium salt was filtered by gravity and after removal of the solvent in the hood, 
the residue was purified with column chromatography using a mixed solvent (10-40% of acetone 
in hexane in volume) to give compound 2 (0.67 g, 74%). Rf    value, 0.26 (Acetone/Hexane, 
30:70, V/V), Mp 120-121 ⁰C. 1H NMR(CDCl3 , δ  ppm) , 2.2(s, 3 H, acetyl)  2.3 (s, 6 H, acetyl), 
6.8 (t, J = 0.36, 1 H), 7.1 (d, J = 8.8, 1 H), 7.2 (q, J = 1.12 Hz, 3 H), 7.6  (d, J = 8.4 Hz, 2 H)  
Synthesis of 1,1’,1’’-(3,4’,5-stilbenyl) 1,6-hexanedioate, 3 
 
 
To a one-neck 50  ml-round-bottomed flask were added resveratrol (0.60 g, 2.63 mmol), 
acetone (20 mL), methyl adipoyl chloride (1.643 g, 9.20 mmol), and triethylamine (1.286 mL, 
9.20 mmol). The mixture was stirred (350 rpm) at r.t. for 16 h. The mixture was acidified using 
2N HCl. The resulting mixture was extracted with ethyl acetate (2 × 20 mL), washed with a 
saturated solution of sodium bicarbonate (3 × 10 mL) and dried with anhydrous magnesium 
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sulfate. The magnesium salt was filtered by gravity and after removal of the solvent in the hood, 
the oily residue was purified with column chromatography using a mixed solvent (10-40% of 
acetone in hexane in volume) to give compound 7 (1.51 g, 88%). Rf  value, 0.32 
(Acetone/Hexane,  30:70, V/V), 
1
H NMR (400 MHz, CDCl3 , δ, ppm),  6.7-7.4 (stilbene, 9 H) 
3.7 (s, 9 H, CH3),  2.4 (t, 6 H, CH2), 2.6 (t, 6 H,CH2), 1.8 (m,  12 H, CH2CH2, 2 H), 
13
C NMR( 
100Mz, CDCl3, δ,  ppm),  23.1,  23.2, 33.1, 33.2, 51.4, 114,156.5, 122, 128, 
129,130,134,140,150,151.5,172, 172.5, 173.
 
Synthesis of 3,5-diacetyloxy-4’-hydroxyl stilbene, 4 
  
 To a one-neck 25 mL-round-bottomed flask were added 2 (100 mg, 0.28 mmol), tert-
butyl methyl ether ( 10 mL) and 1-butanol(0.4 mL). The mixture was stirred in a rotavop at 280 
rpm for 5 minutes to allow 2 to completely dissolve, then lipase Antarctica (100 mg) was added 
and the mixture stirred for 25 minutes. The enzyme was filtered and the resulting mixture 
concentrated and submitted for column chromatography using a mixed solvent (10-40% acetone 
in hexane in volume) to give compound 3 (0.020 g, 22%).  Rf value, 0.32 (Acetone/Hexane, 
40:60, V/V), Mp 120-121 ⁰C. 1H NMR (400MHz, CDCl3, δ, ppm), 2.3 (s, 6 H, acetyl), 6.8 (t, J = 
0.36,1 H), 7.1 (d, J = 8.8, 1 H), 7.2 (q, J = 1.12 Hz, 3 H) 7.6 (d, J = 8.4 Hz, 2 H) 
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Synthesis of methyl 8-(3’,5’-diacetyloxystilbene-4’’-oxy)-3,6-dioxooctanoate, 5 
 
 To a one-neck 10 mL round-bottomed flask were added 4 (0.060 g, 0.20 mmol), THF 
freshly distilled (1 mL), compound 9 (110uL, 0.60mmol), triphenylphosphine (0.162 g, 0.60 
mmol) , and diethylazodicarboxylate (DEAD) (100 uL, 0.60 mmol).  The resultant mixture  was 
stirred at r.t. under N2 atmosphere for 12 h and then concentrated with an evaporator equipped 
with an oil pump. The residue was purified with flash column chromatography (SiO2, 50-60% 
EtOAc/Hexane) to afford 4 as a brown greasy solid (0.067 g, 71.2%).  
1
HNMR(400 MHz,CDCl3 
δ ,ppm),  6.7-7.4 (stilbene, 9 H), 2.3 (s, 6 H), 3.7 (m,4 H), 3.8 ( s, 2 H) ,4.1( s, 3 H) 4.2 (t, 4 H). 
13
C NMR (100 MHz, acetone-d6, δ, ppm), 10.4, 20.1, 52.2, 63.4, 67.8, 68.5, 69.5, 70.25, 115.6, 
116.3, 117.2, 125.8, 127.23, 130.0, 131.9, 140.2, 151.2, 157, 159, 169, 171. 
Synthesis of 8-(3’,5’-dihydroxystilben-4’’oxy)-3,6-dioxooctanoic acid, 9 
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To a three neck 50 mL round- bottomed flask was added compound 4 (0.050 g, 0.11 
mmol), THF (5 mL), methanol (5 mL), and 0.6 M lithium hydroxide (2.0 mL). The resultant 
mixture was stirred for 12 h and then acidified with 2M HCL to pH 2-3. The organic phase was 
extracted with ethyl acetate (3 × 5 mL), then concentrated and purified with flash column 
chromatography (80%/18%/2% acetone/hexane/HOAc, v/v/v) to afford 5, as a brown solid 
(0.017 g, 43.6%) Rf 0.32 (80%/18%/2% acetone/hexane/HOAc, v/v/v).  
1
H NMR (400 MHz, 
acetone-d6, δ, ppm), 6.7-7.4 (stilbene, 10 H), 3.7 (m, 4 H), 3.8 (s, 2 H) 4.2 (t, 4 H).  
Synthesis of 4’oxo-(2’’,3’’-di-O-acetyladenosine)-3,5-diacetyoxylstilbene, 6 
 
To a one-neck 10 mL round-bottomed flask were added 4 (0.050 g, 0.16 mmol), THF 
freshly distilled (1mL), diacetyl adenosine (0.168 g, 0.48 mmol), triphenylphosphine (0.125 g, 
0.48mmol), and diethylazodicarboxylate (DEAD) (75uL, 0.48mmol).  The resultant mixture was 
stirred at r.t under N2 atmosphere for 12 h and concentrated with an evaporator equipped with an 
oil pump. The residue was purified with flash column chromatography (SiO2, 90% 
CH2Cl2/MeOH) to afford 6 as a white solid. But 
1
H NMR spectra was not clean, compound was 
very impure despite a single TLC spot. 
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APPENDICES 
Appendix A: 
1
H NMR spectrum of Compound 2 in CCl3D 
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Appendix B:  
1
H NMR spectrum of Compound 4 in CCl3D 
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Appendix C: 
1
H NMR spectrum of Compound 5 in CCl3D 
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Appendix C: 
1
H NMR spectrum of Compound 5 in acetone-d6/MeOD 
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Appendix D: 
1
H NMR spectrum of Compound 3 in CCl3D 
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Appendix E: 
13
C NMR spectrum of Compound 3 in CCl3D 
 
 
 
  
 71 
 
VITA 
STANLEY MOFOR JING 
Personal Data:   Date of Birth: Feb. 11, 1985 
                                                Place of Birth: Buea-Cameroon 
                                                Marital Status: Single 
 
Education:                          B.S. Chemistry, University of Buea, 2007. 
                                                B.TECH. Chemistry, Cape Peninsula University of Technology,                      
2008.  
 M.S Chemistry, East Tennessee State University Johnson City,     
Tennessee 2011 
 
Professional Experience: Research Assistant. South African Institute for Advanced materials 
Chemistry, SAIAMC, January 2009- December 2009 
Graduate Teaching Assistant, East Tennessee State University, 
    College of Arts and Science, 2010-2011 
